Roivant Sciences Ltd (NASDAQ: ROIV) on Monday, plunged -1.81% from the previous trading day, before settling in for the closing price of $11.6. Within the past 52 weeks, ROIV’s price has moved between $8.73 and $13.06.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -99.51% annually for the last half of the decade. The company achieved an average annual earnings per share of -397.39%. With a float of $419.13 million, this company’s outstanding shares have now reached $695.94 million.
In an organization with 750 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 92.05%, operating margin of -1340.3%, and the pretax margin is -776.7%.
Roivant Sciences Ltd (ROIV) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Roivant Sciences Ltd is 38.35%, while institutional ownership is 71.09%. The most recent insider transaction that took place on Jun 20 ’25, was worth 1,145,000. In this transaction President & COO of this company sold 100,000 shares at a rate of $11.45, taking the stock ownership to the 1,462,223 shares. Before that another transaction happened on Jun 20 ’25, when Company’s 10% Owner sold 577,007 for $11.46, making the entire transaction worth $6,612,500. This insider now owns 37,284,108 shares in total.
Roivant Sciences Ltd (ROIV) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -397.39% per share during the next fiscal year.
Roivant Sciences Ltd (NASDAQ: ROIV) Trading Performance Indicators
Roivant Sciences Ltd (ROIV) is currently performing well based on its current performance indicators. A quick ratio of 33.47 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 101.63.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.25, a number that is poised to hit -0.25 in the next quarter and is forecasted to reach -1.33 in one year’s time.
Technical Analysis of Roivant Sciences Ltd (ROIV)
Let’s dig in a bit further. During the last 5-days, its volume was 7.43 million. That was better than the volume of 5.91 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 61.98%.
During the past 100 days, Roivant Sciences Ltd’s (ROIV) raw stochastic average was set at 86.22%, which indicates a significant increase from 54.05% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 25.06% in the past 14 days, which was lower than the 33.90% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $11.07, while its 200-day Moving Average is $11.22. However, in the short run, Roivant Sciences Ltd’s stock first resistance to watch stands at $11.57. Second resistance stands at $11.74. The third major resistance level sits at $11.90. If the price goes on to break the first support level at $11.23, it is likely to go to the next support level at $11.07. The third support level lies at $10.90 if the price breaches the second support level.
Roivant Sciences Ltd (NASDAQ: ROIV) Key Stats
Market capitalization of the company is 7.74 billion based on 679,806K outstanding shares. Right now, sales total 29,050 K and income totals -171,980 K. The company made 9,020 K in profit during its latest quarter, and 169,380 K in sales during its previous quarter.
